愛爾蘭的糖尿病護理設備市場;投資機會分析與預測

愛爾蘭的糖尿病護理設備市場;投資機會分析與預測 是由出版商Global Markets Direct在2011年12月所出版的。 這份英文市場調查報告書包含Pages: 67 價格從美金2500起跳。

簡介

本報告提供愛爾蘭的糖尿病護理設備市場相關分析，整體市場及各市場區隔的收益·市場規模(銷售台數)·平均價格的實際成果及預測值，流通·企業佔有率調查等，再加上在該國活動中的主要企業概要，為您概述為以下內容。

1 目錄

1.1 表格一覽

1.2 圖表一覽

2 簡介

2.1 關於本報告

3 糖尿病護理設備 - 愛爾蘭

3.1 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)

3.2 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數)

3.3 糖尿病護理設備, 愛爾蘭, 企業佔有率

4 血糖監測儀 - 愛爾蘭

4.1 血糖監測儀 整體收益 (實際成果及預測)

4.1.1 血糖儀 收益 (實際成果及預測)

4.2 血糖監測儀 整體銷售額 (實際成果及預測)

4.2.1 血糖儀 銷售額 (實際成果及預測)

4.3 血糖監測儀 平均價格 (實際成果及預測)

4.4 血糖監測儀 流通佔有率

4.5 血糖監測儀, 愛爾蘭, 企業佔有率

5 胰島素注射器 - 愛爾蘭

5.1 胰島素注射器 整體收益 (實際成果及預測)

5.1.1 胰島素筆 收益 (實際成果及預測)

5.1.2 胰島素幫浦 收益 (實際成果及預測)

5.2 胰島素注射器 整體銷售額 (實際成果及預測)

5.2.1 胰島素筆 銷售額 (實際成果及預測)

5.2.2 胰島素幫浦 銷售額 (實際成果及預測)

5.3 胰島素注射器 平均價格 (實際成果及預測)

5.4 胰島素注射器 流通佔有率

5.5 胰島素注射器, 愛爾蘭, 企業佔有率

6 主要企業概要 - 愛爾蘭 糖尿病護理設備 市場

6.1 F. Hoffmann-La Roche Ltd.

6.1.1 企業概要

6.2 LifeScan, Inc.

6.2.1 企業概要

6.3 Sanofi

6.3.1 企業概要

6.4 Novo Nordisk A/S

6.4.1 企業概要

6.5 Eli Lilly and Company

6.5.1 企業概要

6.6 Bayer HealthCare AG

6.6.1 企業概要

6.7 Abbott Laboratories

6.7.1 企業概要

6.8 Medtronic, Inc.

6.8.1 企業概要

6.9 nipuro

6.9.1 企業概要

6.10 Becton, Dickinson and Company

6.10.1 企業概要

6.11 Terumo Corporation

6.11.1 企業概要

6.12 Animas Corporation

6.12.1 企業概要

7 附錄

7.1 Global Markets Direct 調查方法

7.2 調查對象的市場定義

7.2.1 糖尿病護理設備

7.3 二級研究

7.4 主要研究

7.5 資料的模式化

7.6 預測

7.7 專門委員會的驗證

7.8 貨幣換算

7.9 諮詢方式

7.10 免責聲明

表格一覽

1.1 表格一覽

表格 1: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)

表格 2: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)、 實際成果

表格 3: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)，預測

表格 4: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數)

表格 5: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數), 實際成果

表格 6: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數)，預測

表格 7: 糖尿病護理設備, 愛爾蘭, 企業佔有率 各收益 ($m), 實額(美金)

表格 8: 血糖監測儀, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔, 實際成果

表格 9: 血糖監測儀, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔，預測

表格 10: 血糖儀, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔, 實際成果

表格 11: 血糖儀, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔，預測

表格 12: 血糖監測儀, 愛爾蘭, 銷售額 (台數) 不同市場區隔, 實際成果

表格 13: 血糖監測儀, 愛爾蘭, 銷售額 (台數) 不同市場區隔，預測

表格 14: 血糖儀, 愛爾蘭, 銷售額 (台數) 各子市場區隔, 實際成果

表格 15: 血糖儀, 愛爾蘭, 銷售額 (台數) 各子市場區隔，預測

表格 16: 血糖監測儀, 愛爾蘭, 平均價格 ($), 實際成果

表格 17: 血糖監測儀, 愛爾蘭, 平均價格 ($), 預測

表格 18: 血糖監測儀, 愛爾蘭, 流通佔有率 各收益 ($m), 實額(美金)

表格 19: 血糖監測儀, 愛爾蘭, 企業佔有率 各收益 ($m), 實額(美金)

表格 20: 胰島素注射器, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔, 實際成果

表格 21: 胰島素注射器, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔，預測

表格 22: 胰島素筆, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔, 實際成果

表格 23: 胰島素筆, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔，預測

表格 24: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 收益 ($m), 實額(美金)、 實際成果

表格 25: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 收益 ($m), 實額(美金)，預測

表格 26: 胰島素注射器, 愛爾蘭, 銷售額 (台數) 不同市場區隔, 實際成果

表格 27: 胰島素注射器, 愛爾蘭, 銷售額 (台數) 不同市場區隔，預測

表格 28: 胰島素筆, 愛爾蘭, 銷售額 (台數) 各子市場區隔, 實際成果

表格 29: 胰島素筆, 愛爾蘭, 銷售額 (台數) 各子市場區隔，預測

表格 30: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 銷售額 (台數), 實際成果

表格 31: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 銷售額 (台數)，預測

表格 32: 胰島素注射器, 愛爾蘭, 平均價格 ($), 實際成果

表格 33: 胰島素注射器, 愛爾蘭, 平均價格 ($), 預測

表格 34: 胰島素注射器, 愛爾蘭, 流通佔有率 各收益 ($m), 實額(美金)

表格 35: 胰島素注射器, 愛爾蘭, 企業佔有率 各收益 ($m), 實額(美金)

表格 36: 美金V.S.該地貨幣, 愛爾蘭, 平均實質換算率

圖表一覽

1.2 圖表一覽

圖 1: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)

圖 2: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)、 實際成果

圖 3: 糖尿病護理設備, 愛爾蘭, 整體收益 ($m), 實額(美金)，預測

圖 4: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數)

圖 5: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數), 實際成果

圖 6: 糖尿病護理設備, 愛爾蘭, 各分類銷售額 (台數)，預測

圖 7: 糖尿病護理設備, 愛爾蘭, 企業佔有率 (%)

圖 8: 血糖監測儀, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔, 實際成果

圖 9: 血糖監測儀, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔，預測

圖 10: 血糖儀, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔, 實際成果

圖 11: 血糖儀, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔，預測

圖 12: 血糖監測儀, 愛爾蘭, 銷售額 (台數) 不同市場區隔, 實際成果

圖 13: 血糖監測儀, 愛爾蘭, 銷售額 (台數) 不同市場區隔，預測

圖 14: 血糖儀, 愛爾蘭, 銷售額 (台數) 各子市場區隔, 實際成果

圖 15: 血糖儀, 愛爾蘭, 銷售額 (台數) 各子市場區隔，預測

圖 16: 血糖監測儀, 愛爾蘭, 企業佔有率 (%)

圖 17: 胰島素注射器, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔, 實際成果

圖 18: 胰島素注射器, 愛爾蘭, 收益 ($m), 實額(美金) 不同市場區隔，預測

圖 19: 胰島素筆, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔, 實際成果

圖 20: 胰島素筆, 愛爾蘭, 收益 ($m), 實額(美金) 各子市場區隔，預測

圖 21: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 收益 ($m), 實額(美金)、 實際成果

圖 22: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 收益 ($m), 實額(美金)，預測

圖 23: 胰島素注射器, 愛爾蘭, 銷售額 (台數) 不同市場區隔, 實際成果

圖 24: 胰島素注射器, 愛爾蘭, 銷售額 (台數) 不同市場區隔，預測

圖 25: 胰島素筆, 愛爾蘭, 銷售額 (台數) 各子市場區隔, 實際成果

圖 26: 胰島素筆, 愛爾蘭, 銷售額 (台數) 各子市場區隔，預測

圖 27: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 銷售額 (台數), 實際成果

圖 28: 胰島素幫浦 (傳統胰島素幫浦), 愛爾蘭, 銷售額 (台數)，預測

圖 29: 胰島素注射器, 愛爾蘭, 企業佔有率 (%)

圖 30: Global Markets Direct 調查方法

目錄

Abstract

Summary

"Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017", a new report by Global Markets Direct, provides key market data on the Ireland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

• Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Ireland Diabetes Care Devicesmarket.
• Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, Bayer HealthCare AG and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Ireland Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Introduction

• 2.1 What is This Report About?

3. Diabetes Care Devices In Ireland

• 3.1 Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
• 3.2 Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
• 3.3 Diabetes Care Devices, Ireland, Company Share (2009-2010)

4. Glucose Monitoring In Ireland

• 4.1 Glucose Monitoring Overall Revenue (2003-2017)
  • 4.1.1 Blood Glucose Meters Revenue (2003-2017)
• 4.2 Glucose Monitoring Overall Volume (2003-2017)
  • 4.2.1 Blood Glucose Meters Volume (2003-2017)
• 4.3 Glucose Monitoring Average Price (2003-2017)
• 4.4 Glucose Monitoring Distribution Share (2009-2010)
• 4.5 Glucose Monitoring, Ireland, Company Share (2009-2010)

5. Insulin Delivery In Ireland

• 5.1 Insulin Delivery Overall Revenue (2003-2017)
  • 5.1.1 Insulin Pens Revenue (2003-2017)
  • 5.1.2 Insulin Pumps Revenue (2003-2017)
• 5.2 Insulin Delivery Overall Volume (2003-2017)
  • 5.2.1 Insulin Pens Volume (2003-2017)
  • 5.2.2 Insulin Pumps Volume (2003-2017)
• 5.3 Insulin Delivery Average Price (2003-2017)
• 5.4 Insulin Delivery Distribution Share (2009-2010)
• 5.5 Insulin Delivery, Ireland, Company Share (2009-2010)

6. Overview of Key Companies in Ireland Diabetes Care Devices Market

• 6.1 F. Hoffmann-La Roche Ltd.
  • 6.1.1 Company Overview
• 6.2 LifeScan, Inc.
  • 6.2.1 Company Overview
• 6.3 Sanofi
  • 6.3.1 Company Overview
• 6.4 Novo Nordisk A/S
  • 6.4.1 Company Overview
• 6.5 Eli Lilly and Company
  • 6.5.1 Company Overview
• 6.6 Bayer HealthCare AG
  • 6.6.1 Company Overview
• 6.7 Abbott Laboratories
  • 6.7.1 Company Overview
• 6.8 Medtronic, Inc.
  • 6.8.1 Company Overview
• 6.9 NIPRO CORPORATION
  • 6.9.1 Company Overview
• 6.10 Becton, Dickinson and Company
  • 6.10.1 Company Overview
• 6.11 Terumo Corporation
  • 6.11.1 Company Overview
• 6.12 Animas Corporation
  • 6.12.1 Company Overview

7. APPENDIX

• 7.1 Global Markets Direct Research Methodology
• 7.2 Definitions of Markets Covered in the Report
  • 7.2.1 Diabetes Care Devices
• 7.3 Secondary Research
• 7.4 Primary Research
• 7.5 Models
• 7.6 Forecasts
• 7.7 Expert Panel Validation
• 7.8 Currency Conversion
• 7.9 Contact Us
• 7.10 Disclaimer

List of Tables

• Table 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
• Table 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Historic, 2003-2010
• Table 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
• Table 4: Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
• Table 5: Diabetes Care Devices, Ireland, Category Volume (Units), Historic, 2003-2010
• Table 6: Diabetes Care Devices, Ireland, Category Volume (Units), Forecast, 2010-2017
• Table 7: Diabetes Care Devices, Ireland, Company Share by Revenue ($m), USD Actual, 2009-2010
• Table 8: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
• Table 9: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
• Table 10: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
• Table 11: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
• Table 12: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2003-2010
• Table 13: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
• Table 14: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
• Table 15: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
• Table 16: Glucose Monitoring, Ireland, Average Price ($), Historic, 2003-2010
• Table 17: Glucose Monitoring, Ireland, Average Price ($), Forecast, 2010-2017
• Table 18: Glucose Monitoring, Ireland, Distribution Share by Revenue ($m), USD Actual, 2009-2010
• Table 19: Glucose Monitoring, Ireland, Company Share by Revenue ($m), USD Actual 2009-2010
• Table 20: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
• Table 21: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
• Table 22: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
• Table 23: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
• Table 24: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Historic, 2003-2010
• Table 25: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Forecast, 2010-2017
• Table 26: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2003-2010
• Table 27: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
• Table 28: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
• Table 29: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
• Table 30: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2003-2010
• Table 31: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2010-2017
• Table 32: Insulin Delivery, Ireland, Average Price ($), Historic, 2003-2010
• Table 33: Insulin Delivery, Ireland, Average Price ($), Forecast, 2010-2017
• Table 34: Insulin Delivery, Ireland, Distribution Share by Revenue ($m), USD Actual, 2009-2010
• Table 35: Insulin Delivery, Ireland, Company Share by Revenue ($m), USD Actual 2009-2010
• Table 36: USD to Local Currency, Ireland, Average Actual Rate 2003-2010

List of Figures

• Figure 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
• Figure 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Historic, 2003-2010
• Figure 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
• Figure 4: Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
• Figure 5: Diabetes Care Devices, Ireland, Category Volume (Units), Historic, 2003-2010
• Figure 6: Diabetes Care Devices, Ireland, Category Volume (Units), Forecast, 2010-2017
• Figure 7: Diabetes Care Devices, Ireland, Company Share (%), 2010
• Figure 8: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
• Figure 9: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
• Figure 10: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
• Figure 11: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
• Figure 12: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2003-2010
• Figure 13: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
• Figure 14: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
• Figure 15: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
• Figure 16: Glucose Monitoring, Ireland, Company Share (%), 2010
• Figure 17: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
• Figure 18: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
• Figure 19: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
• Figure 20: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
• Figure 21: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Historic, 2003-2010
• Figure 22: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Forecast, 2010-2017
• Figure 23: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2003-2010
• Figure 24: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
• Figure 25: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
• Figure 26: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
• Figure 27: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2003-2010
• Figure 28: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2010-2017
• Figure 29: Insulin Delivery, Ireland, Company Share (%), 2010
• Figure 30: Global Markets Direct Methodology

相關商品